Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA™ Read more about Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA™
Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China Read more about Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China
Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts Read more about Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts
New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes Read more about New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes
FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer Read more about FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer
Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference Read more about Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
EVENITY™ (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine Read more about EVENITY™ (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine
Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress Read more about Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress
Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting Read more about Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
